Eileen Kennedy

Eileen Kennedy, Ph.D., is a Georgia Athletic Association (GAA) Professor of Pharmacy and Interim Associate Department Head for Education at the University of Georgia’s College of Pharmacy, Department of Pharmaceutical and Biomedical Sciences. Her research spans drug discovery, protein kinase signaling, and innovative education technologies. She holds a leadership role in curriculum development and academic administration.

Her work focuses on developing therapeutics targeting neurodegenerative diseases like Parkinson’s, malaria parasites, and cancer metastasis. She pioneers constrained peptide technologies for kinase modulation and explores educational strategies for global access, including teacher training in conflict zones through collaborative online platforms.

Her publications reflect interdisciplinary expertise in biochemistry, pharmacology, and educational innovation, with recent emphasis on post-pandemic academic resilience, sustainable global collaborations, and the societal impact of digital learning.

Notably, Dr. Kennedy’s research bridges molecular mechanisms (e.g., LRRK2 inhibition, WAVE3 complex disruption) with large-scale educational initiatives like CoMOOCs for refugee learners, demonstrating a commitment to both scientific advancement and equitable knowledge dissemination.